Medidata, a wholly owned subsidiary of France firm Dassault Systèmes (EPA: DSY), has announced a strategic partnership with the East Clinical Center of Oncology (ECCO) and GoBroad Healthcare Group. The collaboration aims to explore the digital transformation of cancer clinical trials and enhance the clinical application of Rave EDC (Electronic Data Collection), Remote Intelligent Clinical Trials (DCT), Medidata AI, and other digital technologies.
Agreement to Utilize Medidata’s Rave EDC in Chinese Clinical Trials
According to the agreement, 42 member units of ECCO and medical institutions of GoBroad Healthcare will adopt Medidata’s industry-leading Rave EDC as their preferred Electronic Data Capture (EDC) solution for clinical trials. This technology will be implemented in Phase I trials of anti-tumor drugs, with the goal of optimizing data management and comprehensively improving the efficiency of experimental data collection. The use of Rave EDC is expected to enhance the quality and completeness of experimental data, thereby advancing the clinical trial process.
Innovative Solutions from MedidataUnified Platform
The MedidataUnified Platform will offer additional innovative solutions such as Remote Intelligent Clinical Trials (DCT) and MedidataAI throughout the trial process. These advancements will provide more efficient and effective ways to conduct clinical trials, potentially revolutionizing the way cancer treatments are researched and developed.-Fineline Info & Tech
